-
- 1800 2010
- EN
-1366x0.jpg)
News
Array
(
[0] => stdClass Object
(
[id] => 1238
[id_crawler] =>
[category_product] => NULL
[thumbnail] => iso_27001/13.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 0
[displayed_time] => 2024-08-14
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2024-08-16 13:52:45
[updated_time] => 2024-08-16 14:42:06
[files] =>
[salary] =>
[time] =>
[created_by] => 63
[is_table_content] => 1
[language_code] => en
[slug] => gentis-leads-as-the-first-to-achieve-2-international-iso-certifications
[title] => GENTIS leads as the first to achieve 2 International ISO Certifications: ISO 15189:2022 and ISO/IEC 27001:2022
[description] => GENTIS, a reputable entity in the field of genetic analysis, is honored to be the first laboratory in Vietnam to achieve two of the latest international ISO certifications: ISO 15189:2022 and ISO/IEC 27001:2022. This is a significant milestone that underscores GENTIS's commitment to providing high-quality genetic testing services, adhering to stringent international standards, and ensuring the highest level of information security.
[content] => On August 13, 2024, GENTIS, the Genetic Analysis Services Joint Stock Company, held a formal ceremony to receive the ISO 15189:2022 Quality Management System certification and the ISO/IEC 27001:2022 Information Security System certification for the GENTIS EUROFINS Laboratory.
- The ISO 15189:2022 VILAS MED 101 certification was assessed and granted by the Bureau of Accreditation (BoA) under the Ministry of Science and Technology of Vietnam.
- The ISO/IEC 27001:2022 certification was assessed and granted by the global professional certification organization Guardian Independent Certification LTD (GICG).
Representatives from the BoA and GICG attended the ceremony
The event was attended by representatives from the Bureau of Accreditation, including Mr. Đặng Quốc Quân, Deputy Director of the office, and Ms. Trần Thị Huyền Trang, Evaluation Specialist. Representatives from the global professional certification organization included Mr. Đặng Minh Tuấn, Director of the company, Mr. Nguyễn Hồng Diệp, Head of Evaluation Department, and Mr. Nguyễn Quốc Chiến, Evaluation Specialist. GENTIS representatives included Mr. Đỗ Mạnh Hà, General Director of the company, Mr. Hà Quốc Khanh, Quality Management Representative, and other management officials.
At the ceremony, Mr. Đặng Quốc Quân, representing the Bureau of Accreditation, expressed: “Achieving ISO 15189:2022 certification marks the beginning of a new journey, requiring continuous effort and determination from the entire GENTIS team to implement quality management. This spirit must be maintained and spread to every employee to fully realize and enhance the benefits that ISO 15189:2022 brings.”
ISO 15189:2022 - The "Gold Standard" for medical laboratories
ISO 15189 is a set of standards outlining the requirements for the quality and competence of medical laboratories. The standard has gone through three versions: ISO 15189:2003, ISO 15189:2007, and ISO 15189:2012. On December 8, 2022, the International Organization for Standardization (ISO) officially issued the fourth version of the standard, ISO 15189:2022.
The ISO 15189:2022 certification is an international standard specifically designed for medical laboratories, ensuring that laboratories operate with the highest levels of accuracy, reliability, and confidentiality. ISO 15189:2022 reflects developments and advances in the field of medical testing, emphasizing risk management, continuous improvement, and integrating quality management into all aspects of laboratory operations.
Mr. Đặng Quốc Quân, representing BoA, presented the ISO 15189:2022 certification to Mr. Đỗ Mạnh Hà, General Director of GENTIS
ISO/IEC 27001:2022 - A commitment to strict and secure information protection
ISO/IEC 27001:2022 is also the latest version of the international standard for information security management. This standard sets out specific requirements for establishing, implementing, maintaining, and continuously improving an Information Security Management System (ISMS).
The 2022 version of this standard includes several updates and improvements over the previous version (2013) to reflect changes in the global information security landscape and emerging threats. The goal of ISO 27001 is to protect the confidentiality, integrity, and availability of information by applying comprehensive risk management measures.
At the ceremony, Mr. Đặng Minh Tuấn, Director of GICG, shared: “The information security system according to ISO 27001:2022 standards will help the organization control and guide activities to ensure cybersecurity and protect customer information. GICG is also always ready to accompany GENTIS to promptly update the latest improvements and advances, bringing the best experiences to customers.”
Mr. Đặng Minh Tuấn, representing GICG, presented the ISO/IEC 27001:2022 certification to Mr. Đỗ Mạnh Hà, General Director of GENTIS
GENTIS and the mission to enhance healthcare services in genetic testing
In September 2023, GENTIS received the ISO 15189:2012 certification for its NIPT, PGT-A, and Thalassemia newborn screening services. To further affirm its efforts in building, developing, and ensuring quality for customers, GENTIS immediately improved and updated the quality in its laboratories to meet the stringent criteria of the ISO 15189:2022 version as soon as it was issued.
At the same time, in the context of personal information and medical data becoming increasingly important and sensitive, achieving ISO/IEC 27001:2022 certification also demonstrates GENTIS's strong commitment to protecting customer data. GENTIS's information security management processes and systems have been rigorously established and controlled to ensure the confidentiality, integrity, and availability of data.
Mr. Đỗ Mạnh Hà, General Director of GENTIS, proudly shared GENTIS's efforts on the journey to achieve ISO 15189:2022 and ISO/IEC 27001:2022 certifications
Achieving the two ISO 15189:2022 and ISO/IEC 27001:2022 certifications not only affirms GENTIS's quality but also reflects the company's continuous efforts to improve and enhance its services. Mr. Đỗ Mạnh Hà, General Director of GENTIS, shared: "We are extremely proud to be the pioneering genetic testing laboratory in Vietnam to achieve the ISO 15189:2022 and ISO/IEC 27001:2022 certifications. This is not only a significant achievement for GENTIS but also an important step forward in improving healthcare services in Vietnam. We are committed to continuously maintaining and enhancing quality standards to provide our customers with the best services."
These two important ISO certifications not only demonstrate GENTIS's continuous efforts in maintaining and improving service quality but also affirm the company's pioneering position in the field of genetic testing in Vietnam. GENTIS is committed to continuing to innovate and apply the latest international standards to bring the best services to customers.
[content_more] => [meta_title] => GENTIS leads as the first to achieve 2 International ISO Certifications: ISO 15189:2022 and ISO/IEC [meta_description] => GENTIS, a reputable entity in the field of genetic analysis, is honored to be the first laboratory in Vietnam to achieve two of the latest international ISO certifications: ISO 15189:2022 and ISO/IEC 27001:2022. This is a significant milestone that unders [meta_keyword] => ISO Certifications,ISO 15189:2022,ISO/IEC 27001:2022 [thumbnail_alt] => [post_id] => 1238 [category_id] => 4 ) [1] => stdClass Object ( [id] => 1237 [id_crawler] => [category_product] => NULL [thumbnail] => hn-di-truyen-3824/gentis_dai_hoc_y-275.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2024-08-08 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2024-08-08 15:20:48 [updated_time] => 2024-08-19 14:29:32 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => gentis-sponsors-and-presents-at-the-2nd-congress-of-vietnam-association-of-medical-genetics-and-genomis-and-the-4th-national-science-conference-2024 [title] => GENTIS Sponsors and Presents at The 2nd congress of Vietnam Association of medical genetics and genomis and The 4th national science conference - 2024 [description] => More than 500 delegates attended the 2nd Congress of the Vietnam Society of Medical Genetics and the 2024 National Scientific Conference, held on August 2-3, 2024, at Hanoi Medical University. This meaningful event is an annual activity organized by the Vietnam Society of Medical Genetics. [content] =>This year's conference focused on the theme "Cancer Genetics and Updates on Advances in Medical Genetics and Genomics," featuring continuous medical education (CME) programs and an official scientific conference that included over 40 presentations on the latest and most in-depth knowledge in the field of medical genetics. The conference welcomed the participation of many genetic experts from both within and outside Vietnam, including Assoc. Prof. Dr. Tran Duc Phan, Assoc. Prof. Dr. Luong Thi Lan Anh, Assoc. Prof. Dr. Tran Van Khoa, Assoc. Prof. Dr. Nguyen Viet Nhan, Assoc. Prof. Dr. Vu Chi Dung, Prof. Dr. Kazuto Kato - Member of the WHO Genetic Advisory Board; Head of the Department of Biomedical Ethics and Social Policy at Osaka University, Prof. Dr. Dominique P. GERMAIN - University of Versailles, Raymond Poincaré University Teaching Hospital…
GENTIS was honored to accompany the conference and introduce to the delegates its comprehensive genetic testing ecosystem in the field of reproductive support using next-generation sequencing technology with the presentation titled "Application of Next-Generation Sequencing in Preimplantation Screening of Microdeletions and Duplications in Embryos" delivered by Dr. Pham Dinh Minh - Director of the GENTIS Genetic Counseling Center during the session "Updates on Advances in Genomic Medicine in Obstetrics 1."
According to Dr. Pham Dinh Minh, microdeletions and duplications in chromosomes are small chromosomal structural abnormalities that can lead to conditions including physical developmental delays, intellectual disabilities, and congenital defects. With the current preimplantation genetic testing for structural rearrangements (PGT-SR) having a resolution of 5-10Mb, smaller structural abnormalities may be missed, leading to severe consequences.
GENTIS is applying next-generation sequencing technology in preimplantation genetic screening for microdeletions and duplications in embryos. Particularly, the PGT-MAX 1 test helps detect abnormalities in the quantity of 24 chromosomes, identifies chromosomal structural abnormalities as small as 2Mb, such as 22q11.2 deletion (DiGeorge syndrome), 1p36 deletion (1p36 deletion syndrome), and other common microdeletions/duplications, and detects mosaicism (20-80%). By reducing the survey gap from 5Mb to 2Mb, the PGT-MAX1 test offers an improved solution for surveying chromosomal structural abnormalities in embryos.
Dr. Pham Dinh Minh's report demonstrated that the application of next-generation sequencing technology in preimplantation genetic screening has enhanced the effectiveness of screening for chromosomal structural abnormalities in embryos, thereby increasing the chances of successful pregnancy and healthy childbirth.
As a sponsor of the conference, GENTIS also exhibited and introduced many materials and product information on PGT in particular and GENTIS testing services in general to experts and doctors. When visiting the GENTIS booth, delegates also participated in a minigame, a lucky spin, and received valuable gifts.
The 2nd Congress of the Vietnam Society of Medical Genetics and the 2024 National Scientific Conference of the Vietnam Society of Medical Genetics provided a valuable opportunity for GENTIS to update its knowledge, engage with the international community on cancer genetics, medical genomics, and reproductive medicine. This allowed GENTIS to interact with numerous experts, introduce meaningful and practical genetic tests, and present the scientific research of its professional team to more than 500 attending delegates.
The conference was indeed a beneficial environment and an opportunity for doctors to share information, exchange knowledge, engage in scientific research, and practice to continuously improve the quality of patient care, aiming for international integration. GENTIS will continue to research and launch useful genetic tests to best support doctors in diagnosing and treating diseases.
[content_more] => [meta_title] => GENTIS Sponsors and Presents at The 2nd congress of Vietnam Association of medical genetics and geno [meta_description] => More than 500 delegates attended the 2nd Congress of the Vietnam Society of Medical Genetics and the 2024 National Scientific Conference, held on August 2-3, 2024, at Hanoi Medical University. This meaningful event is an annual activity organized by the V [meta_keyword] => The 2nd congress of Vietnam Association of medical genetics and genomis [thumbnail_alt] => [post_id] => 1237 [category_id] => 4 ) [2] => stdClass Object ( [id] => 1234 [id_crawler] => [category_product] => NULL [thumbnail] => dsc00253.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2024-08-05 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2024-08-05 11:06:28 [updated_time] => 2024-08-05 11:15:59 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Gentis-Genetic-Counseling-Center-Successfully-Organized-Genetic-Counseling-Talks-No.-2- [title] => GENTIS Genetic Counseling Center Successfully Organized Genetic Counseling Talks No. 2 [description] => With the aim of updating knowledge about genetic counseling and mosaic embryo transfer experiences for clinical doctors, embryologists, and other specialists, the GENTIS Genetic Counseling Center successfully organized Genetic Counseling Talks No. 2: Genetic Counseling in Assisted Reproductive Technology with the theme: "Mosaic Embryo Transfer and Practical Experiences in Vietnam” [content] =>The event featured prominent speakers and chairpersons in the fields of Assisted Reproductive Technology (ART) and Medical Genetics, including Assoc. Prof. Dr. Trinh The Son (Military Medical University), Assoc. Prof. Dr. Nguyen Xuan Hoi (National Obstetrics and Gynecology Hospital), MSc. Dr. Nguyen Duy Phuong (Hanoi General Hospital), Specialist Dr. Nguyen Van Thong (Hung Vuong Hospital), Specialist Dr. Nguyen Thanh Trung (Hanoi Andrology and Infertility Hospital), MSc. Vu Dinh Chat (An Thinh Obstetrics and Gynecology Hospital), and MSc. Nguyen Quang Vinh (GENTIS).
In addition, the event attracted a large number of clinical doctors, genetic experts, embryologists, and lab specialists from hospitals and assisted reproductive centers nationwide. Notably, Genetic Counseling Talks No. 2 was honored by the presence of Prof. Dr. Nguyen Dinh Tao (President of the Hanoi Reproductive Health Society), Assoc. Prof. Dr. Tran Duc Phan (President of the Vietnam Medical Genetics Association), and Assoc. Prof. Dr. Ho Sy Hung (Deputy Director of the National Assisted Reproductive Center).
Opening the program, Assoc. Prof. Dr. Trinh The Son shared: “Mosaic embryo transfer is a topic of great interest in genetics and assisted reproduction, not only in Vietnam but also globally. Currently, doctors performing mosaic embryo transfers primarily follow the research/guidelines of various organizations such as ASRM, ESHRE, PGDIS, ISRG, etc. The number of mosaic embryos transferred has increased significantly. Therefore, standardizing the methods for mosaic embryo transfer, selecting mosaic embryos, and monitoring post-transfer outcomes are crucial.”
“At present, many associations have issued guidelines on mosaic embryo transfer, such as ESHRE and PGDIS. It is evident that these associations are focused on mosaic embryos and related issues, such as the degree of mosaicism, whether to transfers whole chromosome mosaics or segmental mosaics.
At the ESHRE 2024 Conference, mosaic embryo transfer was a hot topic with numerous reports and discussions. A study involving 3000 mosaic embryos showed that lower levels of mosaicism resulted in better neonatal outcomes, pregnancy processes, and implantation rates compared to high-level mosaics. However, outcomes for mosaic embryos were generally lower than those for normal embryos.
Additionally, recommendations at ESHRE 2024 indicated that embryos with over 50% mosaicism could be transferred. Studies also showed that lower levels of mosaicism correlated with better pregnancy and neonatal outcomes. Furthermore, genetic counseling is a critical step in the mosaic embryo transfer process,” said Assoc. Prof. Dr. Nguyen Xuan Hoi.
“Biological factors and technical aspects can cause mosaicism. In embryology labs, non-standardized techniques, biopsy techniques, and cell washing techniques can affect the mosaicism rate. In genetic labs, biases in gene amplification, contamination during library preparation, and initial analysis can cause mosaicism. Therefore, it is essential to establish standardized procedures between embryology and genetic labs to ensure consistent and appropriate mosaicism rates, avoid wasting embryos, and not increase the mosaicism process,” shared MSc. Vu Dinh Chat (An Thinh Obstetrics and Gynecology Hospital).
“Therefore, controlling the quality of testing is crucial. This helps control the rate of mosaic embryos and set appropriate mosaicism reporting thresholds. GENTIS has been and will continue to enhance the resolution of pre-implantation genetic testing to detect more diseases in embryos. Currently, with high-resolution NGS sequencing and specialized bioinformatics software, the PGT-Max 1 test can detect microdeletions as small as 2Mb on 24 chromosomes,” said MSc. Nguyen Quang Vinh (GENTIS).
Speaking about the practical experience of mosaic embryo transfer at Hanoi General Hospital, MSc. Dr. Nguyen Duy Phuong shared, “When receiving pre-implantation genetic testing results indicating mosaic embryos, the challenge for clinical doctors is to explain to patients what mosaic embryos are, whether they can be transferred, and how to monitor the pregnancy if transferred. In practice, monitoring a mosaic embryo pregnancy is more challenging than a normal embryo pregnancy. In addition to routine pregnancy check-ups, patients should have a NIPT test at the 10th week of pregnancy to screen for congenital defects. After that, an amniocentesis is advised at the 16th week, but the decision to proceed depends on the patient.”
“Hanoi Andrology and Infertility Hospital started mosaic embryo transfers in 2020 following PGDIS and ESHRE guidelines. Recently, the hospital has collaborated with GENTIS to conduct scientific research on 'Clinical Outcomes of Patients Transferring Mosaic Embryos.' The overall live birth rate was about 42%, showing that patients without euploid embryos for transfer can consider transferring mosaic embryos,” said Specialist Dr. Nguyen Thanh Trung.
“In practice, mosaic embryo transfer involves clinical, lab testing, and genetic counseling factors. These components are crucial in deciding mosaic embryo transfers and advising patients on the outcomes. We must agree on mosaic embryo transfers and sign consent forms to manage the follow-up process effectively. Therefore, when transferring mosaic embryos, we prioritize the lowest mosaic levels, followed by low levels. Only if patients do not allow mosaic embryo transfers, we will proceed with the next cycle to select normal embryos. Currently, international associations do not recommend discarding mosaic embryos but advise transferring them with patient consent and signed agreements,” added Assoc. Prof. Hoi.
It is evident that recommendations and guidelines for mosaic embryo transfers from global medical organizations are based on genetic factors. Speaking about the significance of genetic counseling in mosaic embryo transfers, Specialist Dr. Nguyen Van Thong (Hung Vuong Hospital) said, “Genetic doctors need to provide thorough counseling to patients to help couples understand the potential risks of transferring mosaic embryos, prioritize mosaic embryo selection, and how to monitor pre- and postnatal conditions. Moreover, psychological support is crucial to help couples reduce anxiety and stress during this process.”
The Genetic Counseling Talks No. 2 with the theme "Genetic Counseling in Assisted Reproductive Technology: Mosaic Embryo Transfer and Practical Experiences in Vietnam" was a great success. GENTIS Genetic Counseling Center sincerely thanks Assoc. Prof. Dr. Trinh The Son and the speakers, Prof. Dr. Nguyen Dinh Tao (President of the Hanoi Reproductive Health Society), Assoc. Prof. Dr. Tran Duc Phan (President of the Vietnam Medical Genetics Association), Assoc. Prof. Dr. Ho Sy Hung (Deputy Director of the National Assisted Reproductive Center), and all participants.
We look forward to welcoming doctors and specialists to future events organized by the GENTIS Genetic Counseling Center!
[content_more] => [meta_title] => GENTIS Successfully Organized Genetic Counseling Talks No. 2 [meta_description] => The GENTIS Genetic Counseling Center successfully organized Genetic Counseling Talks No. 2: Genetic Counseling in Assisted Reproductive Technology with the theme: "Mosaic Embryo Transfer and Practical Experiences in Vietnam” [meta_keyword] => Organized,Gentis,Genetic Counseling Talks,Mosaic Embryo transfer [thumbnail_alt] => [post_id] => 1234 [category_id] => 4 ) [3] => stdClass Object ( [id] => 1232 [id_crawler] => [category_product] => NULL [thumbnail] => iso_27001/chung_nhan_iso_27001.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2024-07-31 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2024-07-31 14:05:45 [updated_time] => 2024-07-31 14:40:32 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => gentis-achieves-isoiec-270012022-certification-affirming-commitment-to-customer-information-security [title] => GENTIS Achieves ISO/IEC 27001:2022 Certification: Affirming Commitment to Customer Information Security [description] => On July 24, 2024, Genetic Testing Service Joint Stock Company (GENTIS) officially received the ISO/IEC 27001:2022 certification from Guardian Independent Certification LTD (GICG), a global professional certification organization. This certification is the international standard for information security management systems. [content] =>Achieving ISO/IEC 27001:2022 certification is a significant milestone for GENTIS in affirming the company’s commitment to safeguarding information and ensuring cybersecurity for customers and partners.
ISO/IEC 27001:2022 is the latest version, meeting all the international standards of information security management. This standard sets out specific requirements for establishing, implementing, maintaining, and continuously improving an Information Security Management System (ISMS). ISO 27001’s goal is to protect the confidentiality, integrity, and availability of information through comprehensive risk management measures.
By building and continuously improving a modern information security management system, GENTIS strongly affirms that its information security management system has been and will continue to be operated strictly in compliance with stringent international standards:
- Comprehensive Information Protection: Ensuring that all information of customers, partners, and the company is confidential, integral, and always available.
- Increasing Customer and Partner’s Trust: ISO/IEC 27001:2022 certification is evidence of GENTIS’s commitment to information protection, thereby enhancing trust and credibility from customers and partners.
- Enhancing Information Security Management Efficiency: Systematic and effective application of information security processes and controls.
- Complying with Laws and Regulations: Ensuring compliance with legal and regulatory requirements related to information security, minimizing legal and financial risks.
GENTIS has undergone a rigorous evaluation process that included multiple stages from risk assessment, establishment of information security controls, to training and raising awareness about information security for all employees. The commitment and efforts of the entire team helped GENTIS excellently meet the requirements of ISO 27001:2022.
Achieving this certification is a significant effort by the entire GENTIS team, who worked together to complete the management processes according to the ISO/IEC 27001:2022 requirements after numerous stringent audits. The ISO/IEC 27001:2022 certification is not only a great achievement but also a motivation for GENTIS to continue improving and developing more robustly in the future.
GENTIS is committed to relentlessly maintaining and improving its Information Security Management System according to international standards. We will tirelessly strive to gain absolute trust in our customers and partners.
This event is significant in the medical field, especially in genetic research and cancer treatment. In 2024, the conference will focus on the theme: "Cancer Genetics and Updates on rêcnt advances in Medical Genetics and Genomics" This theme attracts the attention of leading experts, doctors, and researchers from domestic as well as international.
The conference provides a valuable opportunity for GENTIS to accompany, share, and learn about the latest advances in the genetics and cancer field, aiming to improve the quality of healthcare for patients.
The conference will take place over two days with approximately 40 high-quality scientific reports and lively discussions. Notably, Dr. Pham Dinh Minh, Director of the GENTIS Genetic Counseling Center, will present a scientific report on "Application of NGS in preimplantation screening for embryonic microdeletions and duplications."
As the main sponsor of the conference, GENTIS's booth will feature many special activities such as mini-games, and a lucky spin with many attractive gifts to welcome experts and doctors to visit and experience.
GENTIS looks forward to the interest and companionship of experts, doctors, and scientists to contribute to improving treatment quality and the continuous advancement of the healthcare sector.
As of late, GENTIS has announced 4 genetic cancer screening packages namely: LADYCARE, MENCARE, PRE-CARE, and PRO-CARE aimed at helping customers safeguard their health and that of their loved ones.
THE IMPORTANCE OF CANCER SCREENING
Cancer has always been the most dangerous disease for humans today. In 2020, Vietnam estimated 182,563 new cases and 122,690 deaths from cancer. With 159 new diagnoses and 106 cancer-related deaths per 100,000 people, Vietnam’s rates have risen significantly, ranking 90th for new cases and 50th for cancer-related deaths among 185 countries compared to statistics from 2018.
Various preventive measures have been encouraged, and among them, hereditary cancer screening is the most effective method for early detection of cancer risks even before symptoms appear, enabling tailored plans. Recognizing huge interests of the people, GENTIS has introduced hereditary cancer screening packages tailored to customer needs. 
GENETIC CANCER SCREENING PACKAGES AT GENTIS
GENTIS offers 4 advanced cancer screening solutions to detect abnormalities related to cancer early:
- LADYCARE: Screening 10 genes associated with the 3 most common hereditary cancers in women: breast, ovarian, and colorectal cancer.
- MENCARE: Screening 10 genes associated with the 3 most common hereditary cancers in men: prostate, colorectal, and stomach cancer.
- PRE-CARE: Screening 17 genes associated with the 15 most common hereditary cancers in both genders.
- PRO-CARE: Offers comprehensive screening with 133 genes associated with the 30 most common hereditary cancers in both genders.
At GENTIS, these hereditary cancer screening packages help customers and their families to prevent, reduce risks, and proactively plan effective cancer screenings. With dedicated physicians and expert guidance throughout, GENTIS ensures personalized treatment during the whole screening process. Joining GENTIS today to protect your future and your family’s well-being!
[content_more] => [meta_title] => Explore 4 newly genetic cancer screening solutions at GENTIS [meta_description] => As of late, GENTIS has announced 4 genetic cancer screening packages namely: LADYCARE, MENCARE, PRE-CARE, and PRO-CARE [meta_keyword] => GENTIS,Cancer Screening,Hereditary Cancer [thumbnail_alt] => [post_id] => 1230 [category_id] => 4 ) [6] => stdClass Object ( [id] => 1227 [id_crawler] => [category_product] => NULL [thumbnail] => dsc00876.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2024-07-05 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2024-07-05 14:37:34 [updated_time] => 2024-08-28 14:39:03 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Some-issues-to-discuss-in-genetic-counseling-for-PGT-M-testing [title] => Some Issues to Discuss in Genetic Counseling for PGT-M Testing [description] => Preimplantation genetic testing for monogenic/single gene - PGT-M is a groundbreaking advancement that brings hope to having healthy children to families affected by single-gene hereditary conditions. However, genetic counseling for PGT-M testing remains challenging, primarily due to issues in pre-cycle counseling and the expertise and experience of genetic counselors. This was shared by MSc. Nguyen Thi Huyen, M.D (Specialist in Genetic Counseling at GENTIS Genetic Counseling Center) during the ART ADVANCED 11 Seminar with the theme "Controversial Issues in Assisted Reproductive Technology." [content] =>
he Importance of Genetic Counseling in PGT-M Testing for Assisted Reproductive Technology
PGT-M testing allows couples to select genetically healthy embryos for transfer into the mother's uterus, aiming to prevent the risk of passing on hereditary diseases or disease-causing genes to the next generation. This, in turn, helps manage and alleviate the health, financial, and emotional burdens faced by families affected by genetic disorders. The test is indicated for specific single-gene disorders with clearly identified genetic causes.
MSc. Nguyen Thi Huyen, M.D presented a report on Some Issues to Discuss in Genetic Counseling for PGT-M Testing
Before initiating a PGT-M cycle, doctors identify the genetic cause of the disorder, assess the inheritance pattern, and evaluate the genetic risks. They also explain to patients the potential for false negatives and false positives in the test, as well as the benefits, risks, and possible outcomes of agreeing to undergo PGT-M.
To perform PGT-M, couples must undergo in vitro fertilization (IVF) to create embryos. Once the embryos reach the blastocyst stage, a biopsy is conducted (where 3-5 cells are taken from the part of the embryo that will later develop into the placenta). These biopsied cells are then subjected to specialized testing methods to detect disease-causing genetic mutations. If the mother becomes pregnant following a PGT-M cycle, genetic counselors and clinicians will develop a close follow-up plan for her during the pregnancy.
Challenges and Difficulties in Genetic Counseling for PGT-M Testing
In PGT-M testing, genetic counseling is an important process before, during, and after obtaining the results. MSc. Nguyen Thi Huyen, M.D, explained that genetic counseling in PGT-M faces numerous challenges and difficulties. The most common challenge is ensuring that patients understand their condition well enough to make informed and wise decisions. Additionally, the knowledge and experience of the counselor are vital, as they directly impact the amount and quality of information provided to the patient.
Another significant challenge is identifying the genetic mutations responsible for the disorder or understanding the inheritance patterns, as well as the tools needed to detect these mutations. Other factors affecting PGT-M results include how the embryo biopsy is conducted, the technology used, and whether the results meet the initial expectations. All of these factors will depend on thorough, informative and, importantly, individualized genetic counseling that the patient can understand. Therefore, it is essential to have coordinated counseling from clinical experts, embryology labs, and geneticists before, during, and after the testing, so that patients are fully informed of the benefits and limitations of PGT-M, as well as the challenges in embryo screening, embryo transfer, and prenatal diagnosis.
Moreover, counseling on pregnancy follow-up after embryo transfer is also a challenge for clinical doctors. Coordination with obstetricians is needed to manage the pregnancy effectively, and with pediatricians and geneticists after childbirth.
These insights were presented by MSc. Nguyen Thi Huyen, M.D, Genetic Counselor at GENTIS Genetic Counseling Center, during the ART ADVANCED 11 Seminar titled "Controversial Issues in Assisted Reproductive Technology" held on June 29 in Hanoi. The seminar was honored by the participation of leading experts in Andrology, Assisted Reproductive Technology, Obstetrics, along with many doctors from various centers and hospitals who shared knowledge and discussed the latest scientific and technological advancements to improve the effectiveness of infertility treatments.
Dr. Dang Vinh Dung (108 Military Central Hospital) Presents on “Evaluating the Effectiveness of PRP in Treating Patients with Ovarian Failure”
At the workshop, Dang Vinh Dung, M.D, PhD (108 Military Central Hospital) presented the initial results of applying ovarian rejuvenation using platelet-rich plasma (PRP). He emphasized the effectiveness and practical application of this method in supporting the treatment of ovarian failure. GENTIS is honored to have provided scientific information about the PRP IVF kit to Dr. Dung.
As a sponsor of the ART Advanced 11 Seminar, GENTIS hosted many engaging activities for the attending doctors and delegates at their exhibition booth. The experts in attendance highly appreciated the tests provided, researched, and developed by GENTIS.
The GENTIS booth at the ART ADVANCED 11 Seminar garnered significant interest from doctors.
Over the past 13 years, GENTIS has continuously contributed to the development of the reproductive health field in Vietnam. Committed to delivering high-quality products and services, GENTIS consistently strives to support the community and advance the reproductive healthcare sector
[content_more] => [meta_title] => Some Issues to Discuss in Genetic Counseling for PGT-M Testing [meta_description] => Genetic counseling for PGT-M testing remains challenging, primarily due to issues in pre-cycle counseling and the expertise and experience of genetic counselors [meta_keyword] => GENTIS,PGT-M,Testing [thumbnail_alt] => [post_id] => 1227 [category_id] => 4 ) [7] => stdClass Object ( [id] => 1226 [id_crawler] => [category_product] => NULL [thumbnail] => dsc03356.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2024-07-01 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2024-07-04 15:43:17 [updated_time] => 2024-08-28 14:52:25 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Genetics-is-one-of-the-factors-directly-affecting-male-infertility [title] => Genetics is one of the factors directly affecting male infertility [description] => Male infertility is becoming increasingly common, causing men to feel insecure and affecting family happiness. According to Dr. Mai Ba Tien Dung, PhD.MD. (Head of Andrology Department - Binh Dan Hospital, Ho Chi Minh City), “There are many causes of male infertility. Besides mumps, cancer, injuries from conditions such as varicocele, infections, pelvic surgery, etc., genetics is one of the important factors directly affecting male infertility.” [content] =>Current status of male infertility in Vietnam
So far, the stereotype has been that infertility is mainly due to women. However, according to the latest research by the World Health Organization (WHO), infertility causes come from both men and women.
The Andrology session at the 21st Annual Urology and Nephrology Scientific Conference (HUNA) 2024 attracted the attention of many delegates.
In infertility cases, female factors account for 40%, male factors for 30%, both partners for 20%, and 10% remain unexplained. This data shows that the incidence of male and female infertility is similar. This is why, in recent years, male infertility has been a focus of scientific research and patient care in Vietnam.
In fact, the frequency of male infertility in the community is 15%. This is an alarming number, requiring attention and appropriate programs for screening and treating male infertility.
How do genetic factors affect male infertility?
There are many causes of male infertility. Commonly mentioned ones include mumps, cancer, injuries from conditions such as varicocele, infections, and pelvic surgery. Besides, genetics is also one of the factors.
According to Dr. Mai Ba Tien Dung, PhD.MD. (Head of Andrology Department - Binh Dan Hospital, Ho Chi Minh City), genetics is one of the factors directly affecting male infertility. When genetic factors of infertile patients are surveyed, clinicians can provide suitable treatment methods for each specific individual, thereby personalizing and saving treatment costs for patients.
Dr. Dung also stated that genetic issues have started to develop in Vietnam in recent years. However, the number of facilities capable of performing genetic tests for men is still limited in Vietnam. The development, expansion, and popularization of genetic tests are the shared desire of clinicians to support the examination, diagnosis, and treatment of male infertility.
Fertiscan test mentioned by Dr. Mai Ba Tien Dung, PhD.MD. in the scientific report at HUNA 2024
In his scientific report at the 21st Annual Urology and Nephrology Scientific Conference (HUNA) 2024, held on June 27-29 in Rach Gia City, Kien Giang Province, Dr. Mai Ba Tien Dung, PhD.MD. discussed Fertiscan testing. Dr. Dung used Fertiscan testing to identify key genetic factors related to sperm synthesis in patients, thereby shortening the diagnostic process and reducing treatment costs.
HUNA is an annual scientific conference aimed at connecting Vietnamese and international doctors, nurses, and medical experts. This year’s conference had over 1,000 participants, including leading specialists, doctors, and nurses in urology, nephrology, andrology, kidney transplantation, and dialysis from hospitals both within the country and abroad.
Experts Attending the 21st Annual Urology and Nephrology Scientific Conference (HUNA) 2024
At HUNA 2024, GENTIS had the opportunity to learn, exchange experiences, and update new trends and medical advances in diagnosing and treating andrological diseases. With a team of experts having many years of experience in genetic research, along with well-planned investments in new, highly accurate technologies, GENTIS hopes that genetic tests will assist clinicians in screening, diagnosing, identifying the causes of infertility, and finding appropriate treatment methods
[content_more] => [meta_title] => Genetics is one of the factors directly affecting male infertility [meta_description] => “There are many causes of male infertility. Besides mumps, cancer, injuries from conditions such as varicocele, infections, pelvic surgery, etc., genetics is one of the important factors directly affecting male infertility.” [meta_keyword] => GENTIS,Infertility,Male [thumbnail_alt] => [post_id] => 1226 [category_id] => 4 ) )
GENTIS leads as the first to achieve 2 International ISO Certifications: ISO 15189:2022 and ISO/IEC 27001:2022
GENTIS Sponsors and Presents at The 2nd congress of Vietnam Association of medical genetics and genomis and The 4th national science conference - 2024
GENTIS Genetic Counseling Center Successfully Organized Genetic Counseling Talks No. 2
GENTIS Achieves ISO/IEC 27001:2022 Certification: Affirming Commitment to Customer Information Security
GENTIS accompanies The 2nd congress of Vietnam Association of medical genetics and genomis and The 4th national science conference - 2024
Explore 4 newly genetic cancer screening solutions at GENTIS
Some Issues to Discuss in Genetic Counseling for PGT-M Testing
Genetics is one of the factors directly affecting male infertility
Quý khách vui lòng điền thông tin bên dưới để được hỗ trợ,
tư vấn một cách tốt nhất!
Xem Socolive trực tuyến tiếng Việt
Link Bóng Đá Lu miễn phí
Link Rakhoi TV bóng đá trực tuyến
Xem tructiep https://xoilaczll.tv/
Link trực tiếp MitomTV bình luận tiếng Việt https://f8betht.baby Xem tructiep https://uniscore.com/viQuý khách vui lòng điền thông tin bên dưới để được hỗ trợ,
tư vấn một cách tốt nhất!
